Tenet Healthcare (NYSE:THC) Given "Buy" Rating at Truist Financial
Truist Financial reiterated their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $130.00 price objective on the stock, up from their prior price objective of $120.00. THC has been the subject of a number of other reports. […]